miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis CH Liu, J Ampuero, A Gil-Gómez, R Montero-Vallejo, Á Rojas, ... Journal of hepatology 69 (6), 1335-1348, 2018 | 145 | 2018 |
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ... Nature communications 7 (1), 12757, 2016 | 119 | 2016 |
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes M Eslam, A Mangia, T Berg, HLY Chan, WL Irving, GJ Dore, ML Abate, ... Hepatology 64 (1), 34-46, 2016 | 112 | 2016 |
Effect of quercetin on hepatitis C virus life cycle: from viral to host targets Á Rojas, JA Del Campo, S Clement, M Lemasson, M García-Valdecasas, ... Scientific Reports 6 (1), 31777, 2016 | 108 | 2016 |
Herbal and dietary supplement-induced liver injuries in the Spanish DILI registry I Medina-Caliz, M Garcia-Cortes, A Gonzalez-Jimenez, MR Cabello, ... Clinical Gastroenterology and Hepatology 16 (9), 1495-1502, 2018 | 107 | 2018 |
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis M Eslam, D McLeod, KS Kelaeng, A Mangia, T Berg, K Thabet, WL Irving, ... Nature Genetics 49 (5), 795-800, 2017 | 99 | 2017 |
Metformin inhibits glutaminase activity and protects against hepatic encephalopathy J Ampuero, I Ranchal, D Nunez, MM Díaz-Herrero, M Maraver, JA Campo, ... PLoS One 7 (11), e49279, 2012 | 82 | 2012 |
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection I Carmona, P Cordero, J Ampuero, A Rojas, M Romero-Gomez Clinical microbiology and infection 22 (10), 839-845, 2016 | 56 | 2016 |
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy JA Del Campo, M García-Valdecasas, A Gil-Gómez, Á Rojas, P Gallego, ... PloS one 13 (1), e0191805, 2018 | 43 | 2018 |
Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitro Á Rojas, JA Del Campo, M Maraver, R Aparcero, M García‐Valdecasas, ... Journal of viral hepatitis 21 (1), 19-24, 2014 | 31 | 2014 |
Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study R Muñoz-Hernández, J Ampuero, R Millán, A Gil-Gómez, Á Rojas, ... Clinical and translational gastroenterology 11 (8), e00203, 2020 | 28 | 2020 |
Activation of the oncogenic miR‐21‐5p promotes HCV replication and steatosis induced by the viral core 3a protein S Clément, C Sobolewski, D Gomes, A Rojas, N Goossens, ... Liver International 39 (7), 1226-1236, 2019 | 26 | 2019 |
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism JA Del Campo, J Ampuero, L Rojas, M Conde, A Rojas, M Maraver, ... Alimentary pharmacology & therapeutics 37 (1), 74-80, 2013 | 26 | 2013 |
The hepatitis C virus modulates insulin signaling pathway in vitro promoting insulin resistance JA del Campo, M García-Valdecasas, L Rojas, Á Rojas, ... PLoS One 7 (10), e47904, 2012 | 25 | 2012 |
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation R Gallego-Durán, J Ampuero, H Pastor-Ramírez, L Álvarez-Amor, ... Scientific Reports 12 (1), 3418, 2022 | 19 | 2022 |
Long non‐coding RNA H19 as a biomarker for hepatocellular carcinoma Á Rojas, A Gil‐Gómez, P de la Cruz‐Ojeda, R Muñoz‐Hernández, ... Liver International 42 (6), 1410-1422, 2022 | 17 | 2022 |
International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis Á Díaz‐González, M Sanduzzi‐Zamparelli, LG da Fonseca, ... Liver International 40 (6), 1467-1476, 2020 | 17 | 2020 |
Water-soluble extracts from edible mushrooms (Agaricus bisporus) as inhibitors of hepatitis C viral replication P Gallego, Á Rojas, G Falcón, P Carbonero, MR García-Lozano, A Gil, ... Food & Function 10 (6), 3758-3767, 2019 | 17 | 2019 |
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C J Ampuero, C Jimeno, R Quiles, JM Rosales, S Llerena, N Palomo, ... Journal of hepatology 68 (5), 940-948, 2018 | 17 | 2018 |
Entry of hepatitis C virus into the cell: a therapeutic target JA Del Campo, Á Rojas, M Romero-Gómez World Journal of Gastroenterology: WJG 18 (33), 4481, 2012 | 16 | 2012 |